Jose Mauricio Mota
Jose Mauricio Mota
Instituto do Câncer do Estado de São Paulo
Verified email at hc.fm.usp.br
Title
Cited by
Cited by
Year
Wnt/beta-catenin pathway: modulating anticancer immune response
SG Pai, BA Carneiro, JM Mota, R Costa, CA Leite, R Barroso-Sousa, ...
Journal of hematology & oncology 10 (1), 1-12, 2017
2192017
Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis
PG Czaikoski, JMSC Mota, DC Nascimento, F Sônego, FVS Castanheira, ...
PloS one 11 (2), e0148142, 2016
1792016
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
PMG Soares, JMSC Mota, AS Gomes, RB Oliveira, AMS Assreuy, ...
Cancer chemotherapy and pharmacology 63 (1), 91-98, 2008
1162008
Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner
CW Wanderley, DF Colon, JPM Luiz, FF Oliveira, PR Viacava, CA Leite, ...
Cancer research 78 (20), 5891-5900, 2018
1032018
The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment
LC Connell, JM Mota, MI Braghiroli, PM Hoff
Current treatment options in oncology 18 (4), 23, 2017
1012017
Irinotecan-and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
RA Ribeiro, CWS Wanderley, DVT Wong, JMSC Mota, CAVG Leite, ...
Cancer chemotherapy and pharmacology 78 (5), 881-893, 2016
752016
Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4
PMG Soares, JMSC Mota, EP Souza, PFC Justino, AX Franco, FQ Cunha, ...
Cytokine 61 (1), 46-49, 2013
692013
Amifostine and glutathione prevent ifosfamide-and acrolein-induced hemorrhagic cystitis
C Batista, J Mota, MLP Souza, BTA Leitao, M Souza, GAC Brito, ...
Cancer chemotherapy and pharmacology 59 (1), 71-77, 2007
572007
Complications from carcinoid syndrome: review of the current evidence
JM Mota, LG Sousa, RP Riechelmann
Ecancermedicalscience 10, 2016
462016
Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice
PMG Soares, RCP Lima-Junior, JMSC Mota, PFC Justino, GAC Brito, ...
Cancer chemotherapy and pharmacology 68 (3), 713-720, 2011
422011
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
JM Mota, KA Collier, RLB Costa, T Taxter, A Kalyan, CA Leite, YK Chae, ...
Oncotarget 8 (51), 89284, 2017
322017
Chemotherapy-induced hemorrhagic cystitis: pathogenesis, pharmacological approaches and new insights
RA Ribeiro, RCP Lima-Junior, C Leite, J Mota, FYB Macedo, MVA Lima, ...
J Exp Integr Med 2 (2), 95-112, 2012
282012
Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4/CXCL12 and favors tumor progression in mice
JM Mota, CA Leite, LE Souza, PH Melo, DC Nascimento, ...
Cancer Immunology Research 4 (4), 312-322, 2016
272016
Gastric damage induced by different doses of indomethacin in rats is variably affected by inhibiting iNOS or leukocyte infiltration
M Souza, J Mota, RB Oliveira, FQ Cunha
Inflammation Research 57 (1), 28-33, 2008
262008
Methotrexate-induced intestinal mucositis delays gastric emptying and gastrointestinal transit of liquids in awake rats
PMG Soares, LO Lopes, JMSC Mota, JN Belarmino-Filho, RA Ribeiro, ...
Arquivos de gastroenterologia 48 (1), 80-85, 2011
192011
Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis
FYB Macedo, F Baltazar, LC Mourão, PRC Almeida, JMSC Mota, ...
Experimental and Toxicologic Pathology 59 (6), 425-430, 2008
182008
Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
B Nguyen, JM Mota, S Nandakumar, KH Stopsack, E Weg, D Rathkopf, ...
European urology 78 (5), 671-679, 2020
172020
Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer
Z Zhang, WR Karthaus, YS Lee, VR Gao, C Wu, JW Russo, M Liu, ...
Cancer cell 38 (2), 279-296. e9, 2020
172020
Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations
JM Mota, E Barnett, JT Nauseef, B Nguyen, KH Stopsack, A Wibmer, ...
JCO precision oncology 4, 355-366, 2020
172020
Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: two case reports
JM Mota, LG Sousa, MI Braghiroli, LT Siqueira, JEB Neto, P Chapchap, ...
Medicine 97 (52), 2018
172018
The system can't perform the operation now. Try again later.
Articles 1–20